Similar articles

• An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

  Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M. Barnett AH, et al. Diabetes Care. 2006 Jun;29(6):1282-7. doi: 10.2337/dc05-1879. Diabetes Care. 2006. PMID: 16732009 Clinical Trial.
• An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.

  Kanna B, Abreu-Pacheco H. Kanna B, et al. Diabetes Care. 2007 Feb;30(2):445-6; author reply 446. doi: 10.2337/dc06-2031. Diabetes Care. 2007. PMID: 17259531 No abstract available.
• United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

  [No authors listed] [No authors listed] Ann Intern Med. 1998 Feb 1;128(3):165-75. doi: 10.7326/0003-4819-128-3-199802010-00001. Ann Intern Med. 1998. PMID: 9454524 Clinical Trial.
• Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.

  Riddle MC. Riddle MC. Diabetes Res Clin Pract. 1991 Jan;11(1):3-8. doi: 10.1016/0168-8227(91)90134-y. Diabetes Res Clin Pract. 1991. PMID: 2019232 Review. No abstract available.
• [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].

  Ohmura E, Hosaka D, Imai Y, Kawazu S. Ohmura E, et al. Nihon Rinsho. 2002 Sep;60 Suppl 9:470-5. Nihon Rinsho. 2002. PMID: 12387036 Review. Japanese. No abstract available.